Physician profile

Paul Mischel

Anatomic Pathology & Clinical Pathology · Los Angeles, CA

NPI 1508892514

$7,918.76

in general payments reported to CMS, 2019-2025

5 companies · $149 in 2025

The $149 reported for 2025 was more than what 75% of Anatomic Pathology & Clinical Pathology providers received nationally (typical 2025 total: $50.59).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$4,080.00
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$2,280.00
Food and Beverage$314.56
Travel and Lodging$92.20

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Sage Therapeutics, LLC $2,952.00 2021-2023
Genentech USA, INC. $2,372.20 2024
Genentech, INC. $2,306.67 2024
Abbvie INC. $149.00 2025
Kyowa Kirin, INC. $138.89 2024

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Paul Mischel

$7,918.76

in general payments reported 2019-2025

Years
2021-2025
Top company
Sage Therapeutics, LLC
Context
The $149 reported for 2025 was more than what 75% of Anatomic Pathology & Clinical Pathology providers received nationally (typical 2025 total: $50.59).

https://glasscript.com/doctor/1146778/paul-mischel

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.